References
- Deane S, Selmi C, Teuber SS, Gershwin ME. Macrophage activation syndrome in autoimmune disease. Int Arch Allergy Immunol 2010;153:109–20.
- Emmenegger U, Schaer DJ, Larroche C, Neftel KA. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 2005;135:299–314.
- Ramanan AV, Baildam EM. Macrophage activation syndrome is hemophagocytic lymphohistiocytosis—need for the right terminology. J Rheumatol 2002;29:1105, author reply 1105.
- Sanchez A, Celaya AK, Victorio A. Histoplasmosis-associated hemophagocytic syndrome: a case report. AIDS Read 2007; 17:496–9.
- Mandell GL, Bennett JE, Dolin R. Principles and practice of infectious diseases. 7th ed. Vol. 2. Philadelphia, PA: Elsevier Health Science; 2010.
- Leal FE, Cavazzana CL, de Andrade HF Jr, Galisteo AJ Jr, de Mendonça JS, Kallas EG. Toxoplasma gondii pneumonia in immunocompetent subjects: case report and review. Clin Infect Dis 2007;15;44:62–6.
- Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991;18:29–33.
- Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011 Oct 13;118(15): 4041–52. Epub 2011 Aug 9.
- Ost A, Nilsson-Ardnor S, Henter JI. Autopsy findings in 27 children with haemophagocytic lymphohistiocytosis. Histopathology 1998;32:310–6.
- Kim JM, Kwok SK, Ju JH, Park KS, Park GS, Kim HY, Park SH. Macrophage activation syndrome resistant to medical therapy in a patient with systemic lupus erythematosus and its remission with splenectomy. Rheumatol Int. 2010 Dec 1. [Epub ahead of print]
- Emmenegger U, Frey U, Reimers A, Fux C, Semela D, Cottagnoud P, . Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol 2001;68:4–10.